Avatrombopag
Avatrombopag (pronounced as ava-trom-bo-pag) is a medication used to treat thrombocytopenia, a condition characterized by a low number of platelets in the blood.
Etymology
The name "Avatrombopag" is derived from the words "ava", which is a prefix used in pharmaceutical naming, "trombo" which is derived from "thrombocyte", the medical term for platelets, and "pag", a common suffix for drugs that affect platelet production.
Usage
Avatrombopag is used to increase platelet counts in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. It is also used to treat adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Mechanism of Action
Avatrombopag works by stimulating the production of platelets in the body. It binds to the thrombopoietin receptor, which is involved in platelet production, and mimics the effects of natural thrombopoietin.
Side Effects
Common side effects of Avatrombopag include headache, fatigue, abdominal pain, nausea, and fever. Serious side effects may include blood clots and severe allergic reactions.
Related Terms
- Thrombocytopenia
- Platelets
- Liver disease
- Immune thrombocytopenia
- Thrombopoietin
- Blood clot
- Allergic reaction
External links
- Medical encyclopedia article on Avatrombopag
- Wikipedia's article - Avatrombopag
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski